GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $12,196,000 | +47.5% | 99,374 | +5.3% | 0.02% | +14.3% |
| Q1 2020 | $8,268,000 | -22.1% | 94,412 | -6.9% | 0.02% | -4.5% |
| Q4 2019 | $10,608,000 | -6.9% | 101,452 | +2.4% | 0.02% | -4.3% |
| Q3 2019 | $11,394,000 | -33.4% | 99,046 | -0.2% | 0.02% | -30.3% |
| Q2 2019 | $17,102,000 | +108.6% | 99,208 | +103.9% | 0.03% | +3.1% |
| Q1 2019 | $8,200,000 | +73.1% | 48,644 | 0.0% | 0.03% | +52.4% |
| Q4 2018 | $4,737,000 | -43.6% | 48,644 | 0.0% | 0.02% | -32.3% |
| Q3 2018 | $8,403,000 | +1.5% | 48,644 | -18.0% | 0.03% | -3.1% |
| Q2 2018 | $8,276,000 | -21.2% | 59,306 | -36.4% | 0.03% | -23.8% |
| Q1 2018 | $10,506,000 | -15.5% | 93,249 | -1.0% | 0.04% | -14.3% |
| Q4 2017 | $12,434,000 | +29.9% | 94,193 | -0.1% | 0.05% | +19.5% |
| Q3 2017 | $9,570,000 | – | 94,291 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $25,213,000 | 11.33% |
| Iguana Healthcare Management, LLC | 50,000 | $4,043,000 | 2.16% |
| Ghost Tree Capital, LLC | 35,000 | $2,830,000 | 1.54% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 354,278 | $28,643,000 | 1.06% |
| Cupps Capital Management, LLC | 100,213 | $8,102,000 | 0.75% |
| CLOUGH CAPITAL PARTNERS L P | 192,600 | $15,572,000 | 0.58% |
| FARALLON CAPITAL MANAGEMENT LLC | 244,000 | $19,727,000 | 0.32% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 105,200 | $8,505,000 | 0.31% |
| Eventide Asset Management | 25,000 | $2,021,000 | 0.28% |
| PRUDENTIAL PLC | 836,124 | $67,601,000 | 0.28% |